Job Description The Associate Vice President (AVP), Global Commercial Leader Inflammatory Bowel Disease (IBD), Immunology will lead the global strategy and enterprise launch readiness of our companys next immunology drug for Ulcerative Colitis (UC) and Crohn’s Disease (CD)